logo

Xilio Therapeutics Inc (XLO) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Xilio Therapeutics Inc’s current trading price is -70.57% away from its 52-week high, while its distance from the 52-week low is 120.41%. The stock’s price range over this period has fluctuated between $0.49 and $3.67. The company, operating within the financial sector, had a trading volume of approximately 33.84 million for the day, which was noticeably higher than the average daily share volume of 0.23 million over the last 3 months.

Xilio Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $3.67 on 04/12/23 and a low of $0.49 for the same time frame on 12/20/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Xilio Therapeutics Inc (XLO) has experienced a quarterly rise of 96.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 29.74M and boasts a workforce of 89 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8308, with a change in price of -1.4200. Similarly, Xilio Therapeutics Inc recorded 514,298 in trading volume during the last 100 days, posting a change of -56.80%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for XLO stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.16.

XLO Stock Stochastic Average

Today, Xilio Therapeutics Inc’s raw stochastic average for the past 50 days stands at 40.56%, indicating a rise from the raw stochastic average of the last 20 days, which was 37.04%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 23.85% and 25.17% respectively.

XLO Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 96.36%.However, over the last six months, we can see a stronger performance of -48.82%. Over the last 30 days, the price of XLO has fallen by 63.64%. And in the last five days, it has surged by 53.74%.